Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Results
MRNA logo

Moderna Revenues Surge 260% Amidst $950 Million Patent Settlement

MRNA10-QFiling Date: 5/1/2026
Moderna, Inc.
Description

What this story covers

Moderna reported a 260 percent revenue increase to 389 million dollars in the first quarter of 2026, driven by international vaccine sales. However, a 950 million dollar patent settlement led to a 1 point 3 billion dollar net loss, highlighting ongoing financial impacts from litigation.

Story snapshot

CompanyModerna, Inc.
TickerMRNA
VariantStandard detailed
Duration11:43
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001682852-26-000060
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in